Solid News

The shares of Johnson & Johnson, one of the world's leading retail holdings, are correcting at 167.50.

The asset quotes are falling after the publication of a poor financial report for the second quarter, which reflected a drop in net income by 23% to 4.81B dollars, or 1.8 dollars per share. Last year for the same period, earnings were 6.28B dollars or 2.35 dollars per share. The negative dynamics resulted from a decrease in sales of consumer goods by 1.3% to 3.81B dollars and a decrease in sales of medical devices by 1.1% to 6.9B dollars. As in the previous quarter, the fastest growing sector was the pharmaceuticals segment, which recorded a 6.7% increase in revenue to 13.32B dollars.

The dividend payment is scheduled for September 6, when shareholders receive 1.13 dollars per share, which is approximately 2.70% per annum. The registration will close on August 22.

The trading instrument is being corrected within the global downwards channel, near the support line.

Technical indicators maintain a stable sell signal: fast EMAs on the Alligator indicator are below the signal line, and the AO oscillator histogram forms downward bars.

Resistance levels: 170.20, 177.70. | Support levels: 165.10, 158.10.